Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Ralf C. Bargou, Bernd Dörken|Journal of Clinical Investigation|1997Cited by 765
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study GroupPeter Borchmann, Andreas Engert, Jana Marková et al.|Journal of Clinical Oncology|2011Cited by 190
EBAG9 Adds a New Layer of Control on Large Dense-Core Vesicle Exocytosis via Interaction with SnapinConstantin Rüder, Armin Rehm, Tatiana Reimer et al.|Molecular Biology of the Cell|2005Cited by 41